{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:58:34Z","timestamp":1787021914721,"version":"build-2736575974"},"reference-count":74,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T00:00:00Z","timestamp":1392768000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089189","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T18:21:24Z","timestamp":1392834084000},"page":"e89189","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":94,"title":["Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus"],"prefix":"10.1371","volume":"9","author":[{"given":"Rajmohan","family":"Rajamuthiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth Burgwyn","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elamparithi","family":"Jayamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Larkins-Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Conery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick M.","family":"Ausubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1086\/533590","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus","volume":"46","author":"HW Boucher","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2003-37923","article-title":"Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997\u20132001)","volume":"24","author":"RN Jones","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1072-7515(99)00211-2","article-title":"Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility","volume":"190","author":"GS Gottlieb","year":"2000","journal-title":"J Am Coll Surg"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1469-0691.2006.01589.x","article-title":"Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000","volume":"13","author":"T Benfield","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1574-6976.2007.00086.x","article-title":"Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics","volume":"32","author":"Y Feng","year":"2008","journal-title":"FEMS Microbiol Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijmm.2009.08.013","article-title":"Genomic variation and evolution of Staphylococcus aureus","volume":"300","author":"JA Lindsay","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/PSN.0b013e31818ea7ca","article-title":"Methicillin-resistant Staphylococcus aureus: a new pandemic?","volume":"28","author":"SM Cuddy","year":"2008","journal-title":"Plast Surg Nurs"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"LL Silver","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tim.2005.01.003","article-title":"The worm has turned\u2013microbial virulence modeled in Caenorhabditis elegans","volume":"13","author":"CD Sifri","year":"2005","journal-title":"Trends Microbiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.ppat.0030101","article-title":"Exploiting amoeboid and non-vertebrate animal model systems to study the virulence of human pathogenic fungi","volume":"3","author":"E Mylonakis","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/IAI.71.4.2208-2217.2003","article-title":"Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis","volume":"71","author":"CD Sifri","year":"2003","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1000982","DOI":"10.1371\/journal.ppat.1000982","article-title":"Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus","volume":"6","author":"JE Irazoqui","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1073759","article-title":"A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity","volume":"297","author":"DH Kim","year":"2002","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(02)08713-5","article-title":"Genome and virulence determinants of high virulence community-acquired MRSA","volume":"359","author":"T Baba","year":"2002","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/AAC.00232-06","article-title":"Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics","volume":"50","author":"PM Fox","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1021\/cb100269f","article-title":"Synthetic lethal compound combinations reveal a fundamental connection between wall teichoic acid and peptidoglycan biosyntheses in Staphylococcus aureus","volume":"6","author":"J Campbell","year":"2011","journal-title":"ACS Chem Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1073\/pnas.96.2.715","article-title":"Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis","volume":"96","author":"MW Tan","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1242\/dev.116.3.755","article-title":"Characterization of a germ-line proliferation mutation in C. elegans","volume":"116","author":"MJ Beanan","year":"1992","journal-title":"Development"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/embo-reports\/kvf001","article-title":"SEK-1 MAPKK mediates Ca2+ signaling to determine neuronal asymmetric development in Caenorhabditis elegans","volume":"3","author":"M Tanaka-Hino","year":"2002","journal-title":"EMBO Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1128\/JB.00081-07","article-title":"Anaerobic gene expression in Staphylococcus aureus","volume":"189","author":"S Fuchs","year":"2007","journal-title":"J Bacteriol"},{"key":"ref22","first-page":"403","article-title":"Models of Caenorhabditis elegans infection by bacterial and fungal pathogens","volume":"415","author":"JR Powell","year":"2008","journal-title":"Methods Mol Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/bioinformatics\/btr095","article-title":"Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software","volume":"27","author":"L Kamentsky","year":"2011","journal-title":"Bioinformatics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/cb900084v","article-title":"High-throughput screen for novel antimicrobials using a whole animal infection model","volume":"4","author":"TI Moy","year":"2009","journal-title":"ACS Chem Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/647952","article-title":"Antimicrobial susceptibility testing: a review of general principles and contemporary practices","volume":"49","author":"JH Jorgensen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4161\/viru.22120","article-title":"Community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus virulence toward Caenorhabditis elegans compared","volume":"3","author":"SR Day","year":"2012","journal-title":"Virulence"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1039\/c3lc50264c","article-title":"An integrated microfluidic platform for evaluating in vivo antimicrobial activity of natural compounds using a whole-animal infection model","volume":"13","author":"J Yang","year":"2013","journal-title":"Lab Chip"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/IAI.73.2.872-877.2005","article-title":"Staphylococcus aureus virulence factors identified by using a high-throughput Caenorhabditis elegans-killing model","volume":"73","author":"J Begun","year":"2005","journal-title":"Infect Immun"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/IAI.74.2.1091-1096.2006","article-title":"Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model","volume":"74","author":"CD Sifri","year":"2006","journal-title":"Infect Immun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1155\/2012\/543817","article-title":"A Caenorhabditis elegans host model correlates with invasive disease caused by Staphylococcus aureus recovered during an outbreak in neonatal intensive care","volume":"23","author":"K Wu","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"10892","DOI":"10.1073\/pnas.191378698","article-title":"A simple model host for identifying Gram-positive virulence factors","volume":"98","author":"DA Garsin","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.1073\/pnas.0604055103","article-title":"Identification of novel antimicrobials using a live-animal infection model","volume":"103","author":"TI Moy","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.chom.2013.03.003","article-title":"Pseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and death","volume":"13","author":"NV Kirienko","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1242\/jeb.203.16.2467","article-title":"Broad oxygen tolerance in the nematode Caenorhabditis elegans","volume":"203","author":"WA Van Voorhies","year":"2000","journal-title":"J Exp Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1093\/jac\/dks184","article-title":"Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes","volume":"67","author":"T Suzuki","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"18909","DOI":"10.1073\/pnas.1209126109","article-title":"Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids","volume":"109","author":"S Brown","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","first-page":"86","article-title":"Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions","volume":"17","author":"MA Kielhofner","year":"1990","journal-title":"Tex Heart Inst J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1128\/AAC.40.6.1534","article-title":"Vancomycin-gentamicin synergism revisited: effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus","volume":"40","author":"L Mulazimoglu","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/AAC.17.2.273","article-title":"Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli","volume":"17","author":"WH Hall","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/oxfordjournals.jac.a002694","article-title":"In vitro anti-methicillin-resistant Staphylococcus aureus activity of 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga","volume":"47","author":"A Isnansetyo","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/AAC.43.2.421","article-title":"Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains","volume":"43","author":"ME Jones","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMcp070747","article-title":"Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus","volume":"357","author":"RS Daum","year":"2007","journal-title":"N Engl J Med"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Schito GC, Debbia EA, Pesce A (1996) Susceptibility of respiratory strains of Staphylococcus aureus to fifteen antibiotics: results of a collaborative surveillance study (1992\u20131993). The Alexander Project Collaborative Group. J Antimicrob Chemother 38 Suppl A: 97\u2013106.","DOI":"10.1093\/jac\/38.suppl_A.97"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/AAC.29.3.461","article-title":"Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis","volume":"29","author":"M Gilbert","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","first-page":"153","article-title":"Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus pseudintermedius isolated from various animals","volume":"52","author":"JE Rubin","year":"2011","journal-title":"Can Vet J"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Pohlod DJ, Saravolatz LD, Somerville MM (1988) In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones. J Antimicrob Chemother 22 Suppl D: 35\u201341.","DOI":"10.1093\/jac\/22.Supplement_D.35"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/B978-0-12-397220-0.00005-2","article-title":"Gatifloxacin","volume":"37","author":"ES Al-Abdullah","year":"2012","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.3390\/molecules170910322","article-title":"Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"17","author":"GY Zuo","year":"2012","journal-title":"Molecules"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s002840010106","article-title":"Specific inhibition of 50S ribosomal subunit formation in Staphylococcus aureus cells by 16-membered macrolide, lincosamide, and streptogramin B antibiotics","volume":"41","author":"WS Champney","year":"2000","journal-title":"Curr Microbiol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01963905","article-title":"Comparative in vitro activity of lomefloxacin, a new difluoroquinolone","volume":"8","author":"AM Clarke","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijantimicag.2009.06.021","article-title":"Minocycline\u2013an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii","volume":"34","author":"E Bishburg","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijantimicag.2008.08.024","article-title":"In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany","volume":"33","author":"V Alba","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/jac\/15.4.435","article-title":"Activity of novobiocin against methicillin-resistant Staphylococcus aureus","volume":"15","author":"TJ Walsh","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/AAC.29.2.325","article-title":"In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus","volume":"29","author":"SM Smith","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/AAC.37.3.384","article-title":"In vitro and in vivo antibacterial activities of T-3761, a new quinolone derivative","volume":"37","author":"Y Fukuoka","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"ref56","first-page":"305","article-title":"Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation","volume":"55","author":"Y Sultana","year":"2005","journal-title":"Acta Pharm"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3109\/00365548.2012.657233","article-title":"Successful treatment of right-sided native valve methicillin-resistant Staphylococcus aureus endocarditis and septicaemia with teicoplanin and rifampicin: a case report","volume":"44","author":"K Saravu","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/40.2.179","article-title":"Susceptibility testing of macrolide and lincosamide antibiotics according to DIN guidelines. Deutsches Institut fur Normung","volume":"40","author":"AF Schmalreck","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF01964437","article-title":"Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria","volume":"12","author":"SM Qadri","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/40.3.427","article-title":"In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections","volume":"40","author":"JA Hoogkamp-Korstanje","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1128\/AAC.35.2.345","article-title":"Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus","volume":"35","author":"PA Maple","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"ref62","first-page":"613","article-title":"[In vitro activity of roxithromycin compared to 5 other macrolides against staphylococci]","volume":"36","author":"Y Brun","year":"1988","journal-title":"Pathol Biol (Paris)"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"C Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1090-0233(05)80005-X","article-title":"Modes of action of anthelmintic drugs","volume":"154","author":"RJ Martin","year":"1997","journal-title":"Vet J"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1073\/pnas.0915125107","article-title":"Repositioning of an existing drug for the neglected tropical disease Onchocerciasis","volume":"107","author":"C Gloeckner","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1126\/science.158.3809.1694","article-title":"Salicylanilides: a new group of active uncouplers of oxidative phosphorylation","volume":"158","author":"RL Williamson","year":"1967","journal-title":"Science"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0960-894X(98)00326-6","article-title":"Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel","volume":"8","author":"DJ Hlasta","year":"1998","journal-title":"Bioorg Med Chem Lett"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev.biochem.69.1.183","article-title":"Two-component signal transduction","volume":"69","author":"AM Stock","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mib.2006.01.005","article-title":"Regulation of bacterial virulence by two-component systems","volume":"9","author":"D Beier","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0163-7258(02)00198-5","article-title":"Virulence- and antibiotic resistance-associated two-component signal transduction systems of Gram-positive pathogenic bacteria as targets for antimicrobial therapy","volume":"93","author":"K Stephenson","year":"2002","journal-title":"Pharmacol Ther"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1073\/pnas.95.9.5317","article-title":"Antibacterial agents that inhibit two-component signal transduction systems","volume":"95","author":"JF Barrett","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-0-387-78885-2_16","article-title":"Inhibitors targeting two-component signal transduction","volume":"631","author":"T Watanabe","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/03602538708998307","article-title":"The metabolism and fate of closantel (Flukiver) in sheep and cattle","volume":"18","author":"M Michiels","year":"1987","journal-title":"Drug Metab Rev"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1101\/gad.1308205","article-title":"A systematic RNAi screen for longevity genes in C. elegans","volume":"19","author":"B Hamilton","year":"2005","journal-title":"Genes Dev"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T22:37:43Z","timestamp":1648334263000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089189"}},"subtitle":[],"editor":[{"given":"Gunnar F.","family":"Kaufmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,19]]},"references-count":74,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089189","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,19]]}}}